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Abstract
Drug carriers containing weak acids or bases can promote cytosolic delivery of macromolecules by exploiting the acidic pH of the
endosome. We have prepared two pH-sensitive mono-stearoyl derivatives of morpholine, one with a (2-hydroxy) propylene (ML1) linker and
the other, an ethylene (ML2) linker. The pKa values of lipids ML1 and ML2, when incorporated into liposomes, are 6.12 and 5.91,
respectively. Both lipids disrupt human erythrocytes at pH equal to or below their pKa but show no such activity at pH 7.4. Confocal
microscopy studies suggest partial endosome-to-cytosol transfer of fluorescent dextran (MW 10 kDa) encapsulated in liposomes that
contained 20 mol% of morpholine lipids. Interestingly, co-incubation of morpholine lipids in free or micellar form (without liposomal
incorporation) with dextran resulted in efficient cytosolic delivery. Upon acidification to the endosomal pH, liposomes containing ML1
revealed: (a) leakage of entrapped solute that is independent of solute size; (b) lack of liposomal collapse into micelles as evidenced by
photon correlation spectroscopy and UV light scattering; and (c) minimal inter-bilayer interactions as shown in a fluorescence resonance
energy transfer assay. These observations are consistent with progressive intravesicular reorganization of lipids into stable liposomes of
smaller size, but of more homogeneous distribution, upon acidification. The results emphasize a need to manipulate liposomal formulations
containing ML1 such that ML1 will promote catastrophic collapse of liposomes to mixed micelles upon exposure to acidic pH. It is only then
that micelle-mediated permeabilization of the endosomal membrane will lead to efficient cytosolic delivery of macromolecules originally
loaded in liposomes.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Macromolecules such as genes, oligonucleotides, and
(glyco)proteins show extensive endosomal sequestration
after fluid-phase uptake or receptor-mediated endocytosis
[1–3]. After vesicular uptake, internalized ligands are often
routed to the degradative pathway, which is characterized by
a repertoire of hydrolases such as proteases (e.g. cathepsins),
phosphatases, lipases, and glycosidases [4,5]. Thus, unless
endosomes/lysosomes themselves are target organelles, the
success of macromolecular therapeutics depends in part on
the ability of such drugs to escape from the endosomal
compartment into the cytosol. Provided that such is achieved,
subsequent interaction of the drug with subcellular compo-
nents can cause the desired pharmacological effect [6–8].
Lipid drug carriers based on various weak acids and
weak bases have been utilized to promote the cytosolic
delivery of macromolecules by exploiting the acidic pH of
the endosomal lumen [9]. Numerous pH-sensitive liposomes
reported in the literature are based on the neutralization of
negative charges on weak acids under acidic conditions.
This tends to reduce the hydrodynamic diameter of lipid
headgroups, triggering bilayer-to-hexagonal phase change
and hence promote fusion. Weak-base lipids, on the other
hand, have been used primarily in conjunction with cationic
lipids to improve delivery of entrapped macromolecules by
membrane disrupting or fusogenic activity. However, at
neutral pH, these excess negative or positive charges induce
undesirable interactions with serum proteins and nontarget
tissue leading to rapid elimination of liposomes from the
circulation [10]. Few successful efforts have been made to
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circumvent this difficulty and to provide nonionic pH-
sensitive liposome formulations [11,12]. Our goal is to
systematically develop such a liposome formulation that is
sensitive to a small decrease in pH, wherein micelle-medi-
ated collapse triggers both release of contents and disruption
of the target membrane efficiently.
A lipid drug carrier containing a weakly basic amine and
a hydrophobic tail behaves as a detergent when the nitrogen
is protonated [13–15]. Incorporation of a biodegradable
linkage between the hydrophilic head and the lipophilic tail
minimizes cytotoxicity. Our previous work involving a
series of acyloxyalkylimidazole lipids with membrane-
bound pKa values in the range of 5.0 to 5.2 provided
important insight into the conditions required for successful
endosome-to-cytosol transfer of macromolecules (accompa-
nying manuscript, Chen et al. and Ref. [16]). Acyloxyalky-
limidazoles behaved as expected in response to pH changes
as evident from hemolysis assays and other experiments
reported in the previous report. However, confocal micro-
scopy studies designed to monitor intracellular distribution
of oligonucleotides encapsulated in liposomes containing 20
mol% imidazole lipids revealed a punctate as well as diffuse
fluorescence. These results suggested inefficient cytosolic
delivery of macromolecules using liposomes containing
acyloxyalkylimidazoles.
In this study, we describe the synthesis and biophysical
characterization of morpholine lipids, (2-hydroxy-3-mor-
pholino) propyl stearate (ML1) and (2-morpholino) ethyl
stearate (ML2) (Fig. 1). The pKa of morpholine is 8.36
[17]. Conjugation of stearic acid to the secondary amine
through a linker results in modification of morpholine to
a weaker base with pKa around 6.0. We rationalized that
the higher degree of protonation of morpholine lipids at
endosomal pH, in comparison with their imidazole coun-
terparts, would result in a higher fraction of their cationic,
membrane-disrupting form within the endosome. The first
series of experiments involve characterization of pH-
dependent hemolytic activity of morpholine lipids. Sec-
ondly, confocal microscopy studies were utilized to mon-
itor intracellular distribution of fluorescent probes
entrapped in liposomes containing ML1 or ML2. Finally,
an attempt is made to establish mechanism(s) underlying
partial cytosolic delivery by liposomes containing ML1.
Based on the results, conditions required for efficient
cytosolic delivery of macromolecules with liposomes
containing pH-sensitive detergents are further corrobo-
rated.
2. Materials and methods
2.1. Lipids and chemicals
4-(2-Hydroxyethyl) morpholine, 4-(1,2-dihydroxy-
propyl) morpholine, and stearoyl chloride were purchased
from Aldrich (Milwaukee, WI) and used without further
purification. Pyridine, 2.0 M HCl in diethyl ether and all
anhydrous organic solvents were also purchased from
Aldrich. Egg phosphatidylcholine (EPC), cholesterol
(CHOL), dioleoyl phosphatidylethanolamine (DOPE),
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-
2-1,3-benzoxadiazol-4-yl) (NBD-PE), 1,2-dioleoyl-sn-glyc-
ero-3-phosphoethanolamine-N-(lissamine rhodamine B sul-
fonyl) (Rh-PE), and other phospholipids were obtained
from Avanti Polar Lipids (Alabaster, AL). [3H]-Mannitol,
[14C]-dextran, nigericin, Triton-X-100, and potassium salt
of 2-(p-toluidino) naphthalene-6-sulfonic acid (TNS) were
obtained from Sigma (St. Louis, MO). BODIPY-labeled,
neutral dextran of MW 10 kDa was purchased from
Molecular Probes (Eugene, OR).
2.2. Synthesis of morpholine lipids
ML1 was prepared by modifying the procedure for syn-
thesis of dioleoyl trimethylaminopropane [18]. Stearoyl
chloride (3.3 mmol, 1 g) was dissolved in 5 ml of anhydrous,
stabilizer free, tetrahydrofuran (THF) in a 20-ml glass vial. A
fivefold excess of 4-(1,2-dihydroxypropyl) morpholine (17
mmol) and 0.15 g of pyridine were added into 10 ml of THF
in a 50-ml round bottom flask (RBF). The flask was flushed
with argon, sealed with a ground glass stopper, and placed in
an ice bath. Stearoyl chloride was then added dropwise with
constant stirring for 15 min. After additional 15 min, solvent
was removed in vacuo to yield yellowish oil with some
insoluble precipitate. The crude product was redissolved in
50 ml of hexane and washed twice with 25 ml of 0.1 M KOH
in a 1:1 methanol/water mixture. Following another wash
with 25-ml brine, the hexane fraction was removed and dried
over anhydrous sodium sulfate. The product was further
purified in a silica gel column (1 20-in., 230–400-A˚ mesh,
Aldrich) using ethyl acetate (EtOAc) and methanol (MeOH)
(3:1). The solvent from the pooled fractions was removed in
vacuo to yield transparent oil, which crystallized at RT. The
oily residue/crystals were redissolved in anhydrous diethyl
ether and 2.0 M HCl in diethyl ether added drop by drop to
obtain the yellowish white HCl salt of ML1 (yieldf 50%).
The purity of the product was determined by TLC (Rf = 0.5,
EtOAc/MeOH, 3:1). Molecular weight and chemical struc-
ture were confirmed by ESI-MS (427.9, estimated 427.7)
and 1H NMR (CDCl3, 300 MHz, Varian 300): d 0.96 (t, 3H),
1.31 (br, 28H), 1.68 (s, 2H), 2.25 (m, 2H), 2.47 (m, 4H), 2.61
(m, 2H), 3.77 (d, 2H), 4.08 (m, 1H), and 4.18 (m, 2H),
respectively.
ML2 was synthesized by the above procedure after minor
modifications. 4-(2-Hydroxyethyl) morpholine, a viscousFig. 1. Structures of ML1 and ML2.
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yellow liquid (4.4 mmol, 578 mg), was mixed with 5 ml of
anhydrous dichloromethane (DCM) in a 100-ml RBF.
Following addition of 0.15 g of pyridine, the RBF was
flushed with argon and sealed with a ground glass stopper.
Stearoyl chloride (6.6 mmol, 2 g), dissolved in 5 ml of
DCM in a 20-ml glass vial, was then introduced dropwise
into the RBF with constant stirring at room temperature. The
reaction was monitored using TLC for about 3 h until
completion, after which DCM was removed in vacuo. After
washing with DCM half saturated with ammonia and brine,
the organic fraction was removed in vacuo to obtain yellow
oil. The product was then dissolved in anhydrous diethyl
ether and filtered. The hydrochloride salt of ML2 was
obtained in a manner similar to compound ML1. The white
precipitate (overall yieldf 60%) was filtered, dried, and
tested for purity with TLC (Rf = 0.6, DCM/EtOAc/MeOH,
80:18:2). Molecular weight and chemical structure were
confirmed using ESI-MS (397.9, estimated 397.7) and 1H
NMR (CDCl3, 300 MHz, Varian 300): d 0.96 (t, 3H), 1.29
(br, 30H), 1.67 (d, 2H), 2.31 (t, 2H), 2.49 (m, 4H), 2.64 (t,
2H), 3.67 (m, 4H), and 4.2 (m, 2H), respectively.
2.3. Preparation of liposomes
Blank liposomes were prepared in different buffers for
each experiment. A thin dry film comprised of different molar
ratios of lipids was obtained in a 10-ml RBF by removing
chloroform in vacuo. The filmwas hydrated using 1 or 2ml of
corresponding buffer (pH 7.4, 300 mOsmol/kg) and alter-
natively vortexed and sonicated for approximately 15 min.
Vesicles were then extruded 7 to 10 times through a 0.22-Am
polycarbonate membrane (Millipore) using an extruder
(Lipex Biomembranes, Vancouver, CA). The size of vesicles
formed was determined using a Nicomp 370 particle sizer.
All probes (radiolabeled or fluorescent) were entrapped
within liposomes using a modified minimum volume
entrapment method [19,20]. A thin dry lipid film containing
different molar ratios of EPC, CHOL, DOPE, ML1, or ML2
was prepared in a 10-ml RBF by removing chloroform in
vacuo. The film was then hydrated with an aliquot of
distilled water and subjected to alternate vortexing and
sonication at room temperature for 15 min. Vesicles formed
were quickly shell-frozen in a dry ice/acetone bath and
lyophilized overnight (Lab Conco, Kansas City, MO). The
dry lipid vesicle layer was rehydrated with 100 Al of a stock
solution of [3H]-mannitol (MW 181, specific activity 40
ACi/10 mg/ml) and [14C]-dextran (MW 10 kDa, specific
activity 20 ACi/10 mg/ml) or 100 Al of neutral BODIPY-
dextran (MW 10 kDa, 10 mg/ml) stock in phosphate
buffered saline (PBS). The viscous preparation was alter-
natively vortexed at room temperature and stored at 4 jC for
several hours. An aliquot of PBS (pH 7.4, 300 mOsmol/kg)
was then added to dilute the liposomal preparation to 2 ml;
following which, liposomes were extruded 10 times with an
extruder (Lipex Biomembranes) through a 0.22-Am poly-
carbonate filter (Millipore). Finally, unencapsulated solutes
were separated from liposomal fractions by elution with
respective buffers through Sephadex CL-6B (Sigma) packed
in a 20 1.0-cm glass column.
Subsequent to separation in a Sephadex CL-6B column,
fractions were individually analyzed in a scintillation counter
to determine encapsulation efficiency. The ratio of radio-
activity associated with liposomal fraction (normalized for
total lipid) and total radioactivity associated with liposome
and unentrapped fractions was used to determine encapsu-
lation efficiency. Vesicle size distribution was obtained with
a Nicomp 370 particle sizer. Osmolality of all buffers and
stock solutions was determined by measuring freezing point
depression on a Fiske ONE-TEN osmometer (Norwood,
MA) and in all cases maintained at 300 mOsmol/kg.
2.4. Determination of membrane-bound pKa of morpholine
lipids
Membrane-bound pKa values of morpholine lipids were
determined as described previously [21]. Liposomes con-
taining EPC/DOPE (60:20) and 20 mol% each of CHOL,
ML1, or ML2 were prepared as described under Section 2.3
in 5 mM HEPES, 5 mM ammonium acetate, 5 mM KCl,
154 mM NaCl, and 1 AM nigericin (pH 7.5, 300 mosM/kg).
Preparations were diluted to 100 AM total lipid in the same
buffer containing 2 AM TNS at pH ranging from 3.0 to 9.0
(adjusted using 0.1 M HCl or 0.1 M NaOH, 300 mosM/kg).
All reagents were warmed to 37 jC prior to performing the
experiment. TNS fluorescence was determined at different
pH using an LS-50B spectrofluorometer (Perkin Elmer)
with excitation and emission wavelengths of 321 and 445
nm, respectively. To obtain membrane-bound pKa values,
the raw data were fit to Eq. (1) using nonlinear regression
analysis (WINNONLINR, Pharsight), in which Fo is the
background TNS fluorescence in buffer, Fmax is the TNS
fluorescence upon infinite dilution using Triton-X-100, (H+)
is the proton activity, and c is a measure of the degree of
interaction of TNS with the bilayer.
Fluorescence ðFÞ ¼ Fo þ ðFmax  FoÞ  ðH
þÞc
ðHþÞc þ ðKaÞc ð1Þ
2.5. pH-dependent hemolysis
Human erythrocytes were isolated from blood samples
and suspended in 0.9% saline. Erythrocytes were suspended
at 2.0 107/ml in 50 ml of different buffers: 0.9% NaCl; pH
5.0 (24.3 ml of 0.1 M citric acid and 25.7 ml of 0.2 M dibasic
sodium phosphate, diluted to 100 ml); pH 6.0 (17.9 ml of 0.1
M citric acid and 32.1 ml of dibasic sodium phosphate,
diluted to 100 ml); and pH 7.4 (PBS) [22]. Lipids ML1 or
ML2, dissolved in ethanol, were rapidly injected into 50ml of
erythrocyte-containing buffer using a gas-tight Hamilton
syringe to obtain a final concentration of 0.1 mM lipid in
2% ethanol. Experimental setup was similar to that used in
previous studies [accompanying manuscript, Chen et al.].
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2.6. Cell culture and confocal microscopy studies
The mouse monocyte cell line, RAW 264.7, was
obtained from Professor Rudy Juliano’s lab, Department
of Pharmacology, UNC-CH. Cells were cultured in two-well
glass culture slides (BD Falcon # 354102) using Dulbecco’s
modified eagle’s medium (DMEM-F12, Gibco), 10% fetal
bovine serum, 100 units/ml penicillin, and 100 Ag/ml
streptomycin under 7% CO2 humidified atmosphere at 37
jC. Serum-free media was used for uptake studies and
phenol red-free DMEM containing serum was used during
microscopy.
Neutral BODIPY-labeled dextran of MW 10 kDa dis-
solved in PBS was entrapped within EPC/DOPE (60:20)
liposomes containing 20 mol% of CHOL, ML1, or ML2
by the minimum volume entrapment procedure described
in Section 2.3. Encapsulation efficiencies were 35% and
25% for liposomes containing ML1 and ML2, respectively.
Each liposomal preparation with a total lipid concentration
of 10 mM was diluted to 2.5 mM with serum-free DMEM
prior to incubation. For incubation of dextran with free or
micellar ML1 or ML2 (without liposomal incorporation),
stocks of morpholine lipids dissolved in DMSO were
diluted in serum-free media to obtain a final concentration
of 0.5 mM in 1% DMSO. Prior to microscopy studies,
cells were washed twice with cold PBS and glass cover
slips placed over a few drops of cold, phenol red-free
DMEM (with serum) in each well to form a thin film over
the cells. Cells were then examined under an Olympus
confocal FV300 fluorescence microscope (40 magnifi-
cation) using a fluorescein filter (488 nm) at 2- and 4-h
time points.
2.7. Dual probe leakage assay
EPC/DOPE (60:20) vesicles containing 20 mol% of
ML1, encapsulating both [3H]-mannitol (25% efficiency)
and [14C]-dextran (40% efficiency), were prepared using
the minimum volume entrapment procedure described in
Section 2.3. The final lipid concentration of 10 mM was
diluted to 0.1 mM in 10 ml of buffer (pH 5.0, 6.0, and
7.4) prior to the experiment. Immediately after dilution,
the preparation was drawn into a 10-ml Hamilton glass
syringe. The syringe was then fitted with a filtering
device comprising of two stacked 0.01-Am polycarbonate
filters (Millipore) and rocked gently (Adams Nutator).
Aliquots of 500 Al were taken by applying gentle pressure
Fig. 2. Determination of membrane-bound pKa values of morpholine lipids.
EPC/DOPE (60:20) vesicles containing 20 mol% each of CHOL (open
circles), ML1 (closed triangles), or ML2 (closed circles) were prepared in 5
mM HEPES, 5 mM ammonium acetate, 5 mM KCl, 154 mM NaCl, and 1
AM nigericin (ionophore) at pH 7.5. Preparations were diluted to 100 AM
total lipid in the same buffer containing 2 AM TNS at different pH. TNS
fluorescence was determined at kex 321 nm and kem 445 nm. Data shown
represent mean values from duplicate experiments.
Fig. 3. Hemolysis of human erythrocytes by lipids ML1 (A) and ML2 (B) at
pH 5.0 (closed circles), 6.0 (open circles), and 7.4 (closed triangles).
Erythrocytes were suspended at 2.0 107/ml in 50 ml of different buffers at
37 jC. To each of these, the lipids were added to attain a final concentration
of 0.1 mM in 2% ethanol. At different time intervals, aliquots of 1 ml were
subjected to centrifugation and absorbance of the supernatant measured at
542 nm. Controls for each pH with 2% ethanol caused less than 5%
hemolysis over a period of 1 h. Complete hemolysis was determined with a
0.1% v/v solution of Triton X-100. Data shown represent mean values from
duplicate experiments.
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on the plunger at different time points and transferred
directly into scintillation vials (20 ml, Fisher). The radio-
activity associated with the liposome-free filtrate was
determined in a Packard scintillation analyzer. A dual
DPM assay with preset detection windows (0–12 keV for
[3H] and 12–156 keV for [14C]) was used to obtain the
respective specific activities of the probes. Complete
leakage (100%) was obtained by adding 500 Al of 0.1%
Triton-X-100 to 500 Al of liposomes in pH 7.4 buffer and
measuring radioactivity.
2.8. Size distribution and UV light scattering
Changes in size distribution of liposomes containing ML1
with entrapped dextran and mannitol were monitored at
different pH for 15 min through photon correlation spectro-
scopy using a Nicomp 370 particle sizer. Blank liposomes
containing different molar ratios of EPC, CHOL, DOPE, or
ML1 were prepared as described in Section 2.3 for turbidity
or absorbance measurements. Liposomes were diluted to a
lipid concentration of 0.1 mM with 3-ml PBS (pH 7.4, 300
Fig. 4. Confocal fluorescence micrographs showing intracellular distribution of liposome-encapsulated BODIPY-dextran. RAW 264.7 cells were incubated
with EPC/DOPE/CHOL (60:20:20) liposomes for 2 and 4 h (A and D); EPC/DOPE/ML1 (60:20:20) liposomes for 2 and 4 h (B and E); and EPC/DOPE/ML2
liposomes for 2 and 4 h (C and F). The total lipid concentration was 2.5 mM. Cells were also incubated with dextran alone (G) or along with 0.5 mM lipids
ML1 or ML2 in serum-free medium (1% DMSO) for 4 h at 37 jC (H and I).
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mOsmol/kg) in a quartz cuvette. The buffer was acidified to
pH 4.8 by quickly injecting a predetermined quantity of 0.1
M citric acid (aliquots less than 100 Al) into the cuvette.
Absorbance was recorded at a wavelength of 350 nm. This
wavelength is the region where changes in particle size will
have a large effect on the optical density due to light scat-
tering without any interference from lipid absorbance [23].
3. Results
3.1. Effect of pH on charge and membrane-disrupting
behavior of ML1 and ML2
The charge on the surface of liposomes containing
ionizable lipids can be determined using TNS, a probe that
reports membrane potential [21]. Briefly, TNS is a lipophilic
anion, which is nonfluorescent in aqueous solution, but
exhibits an increase in fluorescent quantum yield upon
partitioning into the membrane. Thus, changes in TNS
fluorescence in response to changes in pH will reflect upon
the extent of protonation of ML1 or ML2 in the liposomal
bilayer. As shown in Fig. 2, a change in TNS fluorescence is
seen with respect to pH in the presence of liposomes
composed of EPC/DOPE (60:20) and ML1 or ML2 (20
mol%). Membrane-bound pKa values of 6.12 and 5.91 were
obtained by fitting the data to Eq. (1) for ML1 and ML2,
respectively. In addition, a comparison of TNS fluorescence
intensity between the two liposomal formulations (at any
given pH) reveals a consistently higher degree of partition-
ing of TNS into liposomes containing ML2 than those
containing ML1.
Hemolysis of human erythrocytes in the presence of
ML1 or ML2 at different pH clearly demonstrates pH-
dependent, membrane-disrupting capacity of the two lipids.
As seen in Fig. 3A, ML1 promotes complete lysis of
erythrocytes within 5 min at pH 5.0. A slower rate of
hemolysis is detected at pH 6.0 and virtually no hemolytic
activity seen at pH 7.4 for as long as 60 min. Compound
ML2, on the other hand, disrupts erythrocytes completely
only after 30 min at pH 5.0 (Fig. 3B). In addition, ML2 is
unable to promote hemoglobin leakage at pH 6.0 or 7.4.
Both lipids appear to display an initial burst in leakage,
followed by a lag phase and then an exponential release. In
summary, morpholine lipids display pH-sensitive, detergent-
like behavior at pH equal to or below their pKa. Lipid ML1
displays a relatively higher membrane-bound pKa (6.12) and
greater membrane-disrupting ability under acidic conditions
than lipid ML2 (pKa 5.91).
3.2. Cytosolic delivery of BODIPY-dextran
Cellular uptake of BODIPY-labeled dextran mediated by
liposomes that contained EPC/DOPE (60:20) with 20 mol%
of ML1 or ML2 was monitored using confocal microscopy.
Liposomes containing EPC/DOPE/CHOL (60:20:20) were
used as a standard for comparison. As seen in Fig. 4, cellular
uptake of the standard formulation resulted in aggregates
with minor differences in intracellular distribution between
2 and 4 h (A and D). Uptake of liposomes containing 20
mol% of ML1 or ML2 resulted in predominantly punctate
fluorescence after 2 h (B and C) and a partially punctate
pattern of fluorescence after 4 h of incubation (E and F).
In addition, the intracellular distribution of BODIPY-
dextran in RAW 264.7 cells after co-incubation with 0.5
mM ML1 or ML2 in 1% DMSO (without liposomal formu-
lation) was determined after 4 h in a similar manner (Fig. 4).
While fluid-phase pinocytic uptake of dextran alone results in
punctate fluorescence (G), concurrent treatment with ML1 or
ML2 generates a clearly recognizable diffuse fluorescence (H
and I, respectively). In summary, liposomes containing mor-
pholine lipids appear to promote partial cytosolic delivery of
dextran. However, ML1 and ML2 facilitate cellular delivery
more efficiently in their free or micellar form than in lip-
osomal formulations. In addition, ML1 appears to display a
relatively better ability to promote endosome-to-cytosol
transfer in RAW 264.7 cells than ML2. As a result, further
biophysical characterization of ML1 alone was pursued.
3.3. Dual probe liposome leakage assay
The dual probe leakage assay was designed to (a) under-
stand the mechanism of leakage from liposomes containing
ML1 and (b) simultaneously determine the effect of entrap-
ped probe size on leakage. EPC/DOPE (60:20) liposomes
containing 20 mol% ML1 show pH-dependent release of
entrapped probes (Fig. 5). While a relatively slow release
was detected at pH 7.4 upon storage overnight at room
temperature, approximately 10.0% for [3H]-mannitol and
Fig. 5. Leakage of [3H]-mannitol (closed symbols) and [14C]-dextran (open
symbols) from ML1/EPC/DOPE liposomes at pH 5.0 (circles) and 6.0
(triangles). Probes were co-encapsulated using the minimum volume
procedure. Radioactivity was measured using a dual DPM assay. Complete
leakage was determined by rupturing liposomes with a 0.1% v/v solution of
Triton X-100. ML1/EPC/DOPE liposomes showed approximately 10.0%
leakage for [3H]-mannitol and 3.0% for [14C]-dextran at pH 7.4 upon
storage overnight at room temperature.
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3.0% for [14C]-dextran, release rates at pH 5.0 and 6.0 are
rapid and nearly identical. More importantly, vesicles con-
taining ML1 released [14C]-dextran (MW 10 kDa) and [3H]-
mannitol (MW 181) in an identical fashion at pH 5.0 and
6.0, but not at pH 7.4. In addition, upon comparison with
complete (100%) leakage promoted by 0.1% v/v Triton-X-
100, liposomes containing ML1 released approximately
95% of radiolabeled probes at pH 5.0 and 85% at pH 6.0
in 30 min. In summary, liposomes containing ML1 released
entrapped probes in a pH-dependent but size-independent
fashion. Having verified the ability of liposomes containing
ML1 to release entrapped contents upon exposure to acidic
pH, our next step was to investigate events in the lipid
bilayer under similar conditions.
3.4. Size distribution and UV light scattering
Size distribution of EPC/DOPE/ML1 (60:20:20) vesicles
was analyzed using photon correlation spectroscopy with a
Nicomp 370 particle sizer. The Gaussian distribution (vol-
ume-weighted) shows a leftward shift indicating a moderate
decrease in vesicle size in response to a decrease in pH (Fig.
6A). In addition, the decrease in standard deviation (nar-
rower distribution) suggests the formation of a more homo-
geneous population of vesicles. Different liposomal
formulations containing ML1 were also characterized at
37 jC for changes in UV absorption spectra at 350 nm.
UV spectra were obtained over a time interval of approx-
imately 3 min, during which liposomal suspensions were
acidified or disrupted with Triton 100. As seen in Fig. 6B,
unlike Triton-X-100, the cationic form of ML1 in EPC/
DOPE liposomes is unable to promote complete disruption
of liposomes into mixed micelles. A similar lack of collapse
is apparent in case of EPC/CHOL/ML1 liposomes upon
acidification. In summary, these results support (a) the
formation of vesicular remnants and (b) a lack of disruption
of liposomes containing ML1 into mixed micelles.
4. Discussion
We have synthesized morpholine lipids ML1 and ML2
with identical head group and lipid tail, but different linker
moieties (Fig. 1). While ML1 has a relatively longer,
hydrophilic (2-hydroxy) propylene linker, ML2 contains a
shorter, hydrophobic ethylene spacer. The –OH function
present in ML1 was expected to cause significant differ-
ences in the physicochemical behavior of the two lipids due
to its potential to form H-bonds with H2O as well as
neighboring lipid head groups in the liposomal bilayer. Of
various phenomena expected, decreased partitioning of
ML1 into the bilayer [24] leading to its higher membrane-
bound pKa and significantly different membrane packing
[25] may be relevant to the present study. The strong
hydrophilic interactions in the outer leaflet of bilayers
containing ML1 also explain the decreased partitioning of
TNS into liposomes containing ML1 than those containing
ML2 (Fig. 2).
The two lipids did indeed show significant differences in
their ability to lyse human erythrocytes at different pH (Fig.
3). The initial rise in hemoglobin leakage, seen during the
first minute, is presumably a result of membrane destabili-
zation upon immediate partitioning of the octadecyl chain of
the morpholine lipids, when introduced into the cell sus-
pension [26,27]. In agreement with similar studies, a sub-
sequent lag phase is seen at pH 6.0 for ML1 and at pH 5.0
for ML2, reflecting the time required for the surface-active,
cationic lipids to adhere to the outer surface of the eryth-
rocyte membrane. This is in turn thought to facilitate
removal of proteins and phospholipids through formation
of mixed micelles and promote rapid pore-mediated leakage
[27,28]. Except for the initial partition-mediated release, the
neutral form of both lipids lacks hemolytic activity.
When BODIPY-dextran encapsulated in liposomes con-
taining either ML1 or ML2 was fed to cells, very little was
Fig. 6. (A) Gaussian volume-weighted particle size distribution of EPC/
DOPE liposomes containing ML1 obtained by photon correlation
spectroscopy using a Nicomp 370 particle sizer. Distributions were
determined over a 5-min time interval in the following order from front
to back; pH 5.0 (red bars), pH 6.0 (blue), and pH 7.4 (black). (B) Light
scattering by different liposomal suspensions at 350 nm. Different
liposomal formulations suspended in 3-ml PBS in a quartz cuvette were
acidified at the time shown (large arrow heads) with a 50-Al aliquot of citric
acid to pH 4.82. A 1% solution of Triton-X-100 was used to disrupt the
vesicles completely (thin arrows). The absorbance was continuously
monitored at 350 nm.
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accumulated in the cytosol (Fig. 4D and F). Interestingly, a
clearly recognizable cytosolic distribution is seen when
ML1 or ML2 dissolved in DMSO is introduced to the cell
culture (Fig. 4H and I). This observation is consistent with
adsorptive pinocytosis of morpholine lipids along with
fluid-phase uptake of BODIPY-dextran and subsequent
disruption of the endosomal membrane at the endosomal
pH by protonated ML1. Our results are further supported by
similar studies with pH-sensitive lipids such as N-dodecyl
imidazole [29,30]. The mechanism of action of such lyso-
somotropic detergents is thought to be mediated by selective
uptake into lysosomes, where surface activity leads to
rupture of the lysosomal membrane and release of enzymes.
Membrane permeabilization at the plasma membrane level
is ruled out, for neither ML1 nor ML2 displays any
membrane-disrupting ability at pH 7.4.
As shown in Fig. 5, both mannitol of MW 181 and
dextran of MW 10,000 leaked from ML1-containing
liposomes at a nearly identical rate at both pH 5.0 and
6.0, implying total collapse of vesicular structure. This is
patently not the case, for photon correlation spectroscopy
and UV light scattering experiments clearly indicate that
liposomes reorganized themselves to a more homogene-
ous population of smaller vesicles (Fig. 6A and B).
Although the data presented in this study do not allow
elucidating molecular events involved in the pore-medi-
ated leakage, the observations presented in Figs. 5 and 6
are consistent with a notion that leakage was completed
while the liposomes underwent alternative pore formation
and lipid reassembly leading to bilayer stabilization upon
acidification. This process is analogous to the model for
osmotic lysis of liposomes proposed by Koslov and
Markin [31].
When translated to a cellular setting, acidic endosomal
pH could have triggered release of liposome-entrapped
BODIPY-dextran into the endosomal lumen as the lip-
osomes reorganize themselves to another population of
vesicles (process C in Fig. 7). The finding that they do
not form mixed micelles (Fig. 7, process B) would then
imply a paucity of free ML1 available for permeabilizing the
endosomal membrane. The other intervesicular event that
could have promoted endosome-to-cytosol solute transfer is
membrane fusion (Fig. 7, process A). In order to determine
if this occurs or not, we monitored the extent of lipid–lipid
interactions between ML1-containing liposomes and endo-
some-like vesicles [32] at different pH using the fluorescence
resonance energy transfer assay [33]. Unlike pH-sensitive
oleic acid-containing liposomes [34], which displayed
f 40% lipid mixing at pH 5.0, liposomes containing ML1
behave similar to conventional EPC/DOPE/CHOL lipo-
somes and show only 15% lipid mixing regardless of pH
(plots not shown).
Fig. 7. Schematic representation of postulated behavior of ML1/EPC/DOPE liposomes during endocytosis. ML1 inhibits fusion between DOPE-containing
vesicles and the inner leaflet of the endosomal membrane (A) and fails to promote collapse into mixed micelles (B). Instead, a more homogeneous population
of smaller vesicles is formed, during which, efficient leakage of entrapped macromolecules occurs within the endosomal lumen (C). Overall, cytosolic delivery
is inefficient since free ML1 is not available for endosomal permeabilization.
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Bilayer-stabilizing behavior of positively charged ML1 is
analogous to that of lysolecitihin and dodecylimidazolyl
propionate in liposomes containing DOPE or CHOL [35–
39]. Shape complementarity and H-bonding would lead to
tighter packing of the outer leaflet of the bilayer and increased
curvature. Our results are also corroborated by a similar
attempt to enhance cytosolic delivery of carboxyfluorescein
using liposomes containing lysophosphatidylcholine; lysoli-
pid enhanced leakage from liposomes, however, showed no
appreciable effect on cytosolic transfer [40].
In retrospect, collapse of ML1 containing liposomes at
the endosomal pH to micelles can probably be achieved by
manipulating lipid composition or by incorporating higher
concentrations of detergent. While the former would require
a trial and error approach, the latter poses a formidable
challenge. Attempts to incorporate more than 20 mol%
morpholine lipid into vesicles resulted in unstable liposomal
formulations. This observation is also consistent with other
studies with micelle-favoring lysolecitihin and dodecylimi-
dazolyl propionate [41,42]. Such formulations require sub-
stantial amounts of bilayer-stabilizing lipids, such as
cholesterol, in order to maintain their integrity. Thus, our
results emphasize the need for strategies to incorporate
higher concentrations of non-bilayer forming lipids, such
as detergents, into intact liposomal formulations.
5. Conclusion
We have synthesized two pH-sensitive weak base lipids:
ML1 and ML2. Under acidic conditions, ML1 displays a
better ability to disrupt erythrocyte membranes and promote
cytosolic delivery of macromolecules than lipid ML2. When
incorporated into EPC/DOPE liposomes, ML1 shows a
reduced, instead of enhanced, cytosolic delivery of dextran
of MW 10 kDa. This is in spite of the fact that ML1-
containing liposomes efficiently release entrapped probes at
acidic pH.
Further characterization revealed their inability to collapse
into mixed micelles or interact with endosome-like mem-
branes upon acidification. This in turn precludes endosomal
permeabilization and cytosolic release. In conclusion, the
results suggest that endosome-to-cytosol transfer can be
achieved using such pH-sensitive liposomes, only when they
can collapse into mixed micelles under acidic conditions. In
order to achieve saturation and solubilization of liposomes
under acidic conditions, formulations incorporating higher
concentrations of ML1 would be required. Our research
efforts are currently focused on developing such formulations
for the efficient cytosolic delivery of macromolecules.
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